CYP2D6 is a drug-metabolizing enzyme that breaks down many medications – including antidepressants, antipsychotics, and opioids, which can indirectly affect sleep. However, a direct link between CYP2D6 variants and sleep quality or duration is not supported by robust human studies. Myths often claim that a CYP2D6 test reveals whether you are a 'morning person' or 'night owl' – that is false. Sleep-wake regulation is primarily governed by genes like PER, CLOCK, and CRY, not CYP2D6. A CYP2D6 test can be useful for adjusting medication dosages, but not for diagnosing or treating sleep issues. The evidence for a direct sleep effect is weak and largely marketing-driven. Consumers should not rely on such tests to explain sleep problems. For real sleep disorders, medical evaluation and sleep studies are appropriate.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-8b18374f27c84ba62626c43a